Two Sigma Investments, LP Acadia Pharmaceuticals Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 1,110,256 shares of ACAD stock, worth $19 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,110,256

Previous 347,717 219.3%

Holding current value

$19 Million

Previous $5.65 Million 202.41%

% of portfolio

0.04%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $11.5 Million - $14.6 Million	762,539 Added 219.3%	1,110,256 $17.1 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $3.48 Million - $4.39 Million	238,288 Added 217.76%	347,717 $5.65 Million
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $4.26 Million - $7.38 Million	-239,299 Reduced 68.62%	109,429 $2.02 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $5.79 Million - $8.85 Million	278,628 Added 397.47%	348,728 $10.9 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $6.18 Million - $9.93 Million	-296,688 Reduced 80.89%	70,100 $1.46 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $4.64 Million - $6.68 Million	260,588 Added 245.37%	366,788 $8.78 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $1.55 Million - $1.99 Million	95,063 Added 853.58%	106,200 $2 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $158,145 - $207,482	11,137 New	11,137 $177,000
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $2.36 Million - $4.95 Million	-181,671 Reduced 75.55%	58,800 $828,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $4.49 Million - $5.9 Million	214,371 Added 821.34%	240,471 $5.82 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $174,616 - $281,736	10,400 Added 66.24%	26,100 $609,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $29,982 - $47,063	1,900 Added 13.77%	15,700 $261,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $267,720 - $378,396	13,800 New	13,800 $337,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $10.4 Million - $16.3 Million	-286,618 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $11.3 Million - $15.1 Million	286,618 New	286,618 $13.9 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $2.26 Million - $3.35 Million	-71,480 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $5 Million - $7.09 Million	-138,016 Reduced 65.88%	71,480 $3.06 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $241,598 - $478,520	10,873 Added 5.47%	209,496 $7.54 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $4.63 Million - $5.59 Million	198,623 New	198,623 $5.31 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Acadia Pharmaceuticals Inc Transaction History